Fungal resistance in skin infections
Part of Infections, Skin clinical trials.
This study looks at how common antifungal resistance is in fungal skin infections. If you join, doctors will check the type of fungus and see if it resists standard treatments, which may help guide better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a fungal skin infection (like ringworm or athlete's foot).
- You are not currently using any antifungal treatment (cream or pills) for this infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well antifungal medicines work against different fungi and how fungi become resistant. By joining, you may help doctors understand your infection and improve future treatments.
This study is looking at hard-to-treat fungal skin infections to see what they look like under a microscope and under special skin imaging (dermoscopy). It may help find better ways to treat these stubborn infections.
This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
This study looks at Candida infections that are hard to treat, especially when the body's defenses are weak or after medical procedures. It aims to understand why some Candida become resistant to antifungal medicines and form protective layers called biofilms.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
Hear when a new Dermatophyte Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.